HLA Therapeutics

Our Mission

HLA Therapeutics mission is to translate the basic and clinical scientific discovery of HLA/LILR checkpoint blockade into life saving cancer therapy by leveraging the body’s own innate and adaptive immune system to work together and improve patient survival.

Our STrategy

A novel cancer immunotherapy treatment for CAR-T cell and immune checkpoint resistant metastatic solid tumors through activation of innate and adaptive immune responses using a specific pan-a-HLA mAb (DX17 or W6/32) that does not interfere with TCR, or CD94/NKG2A/C or KIR interaction.

Web Design

Lorem ipsum dolor amet, consectetur adipiscing elit, sed do eiusmod tempor.

Reliable Results

Lorem ipsum dolor amet, consectetur adipiscing elit, sed do eiusmod tempor.

Web Development

Lorem ipsum dolor amet, consectetur adipiscing elit, sed do eiusmod tempor.

Social Media

Lorem ipsum dolor amet, consectetur adipiscing elit, sed do eiusmod tempor.

SEO

Lorem ipsum dolor amet, consectetur adipiscing elit, sed do eiusmod tempor.

Graphic Design

Lorem ipsum dolor amet, consectetur adipiscing elit, sed do eiusmod tempor.

Smart and Intuitive

Elementum sagittis vitae

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.

Commodo elitat imperdiet

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.

Quis veleros donecac

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.

100K

Cups of cofee

50+

Blocks

100%

Support

120+

Work hours

It’s time to create

Do you have any question? Feel free to contact us anytime.